Pharmacy

A descriptive text field in pharmacy compounding and PBM systems capturing the clinical or operational justification for selecting a specific drug preparation type. Used in prior authorization workflows, compound drug claims adjudication, and EHR medication order records to document medical necessity and support audit compliance.

The date a specific drug formulation was received into a pharmacy, compounding facility, or medication inventory system. Used in pharmaceutical supply chain tracking, lot management, and drug procurement workflows to establish receipt timelines for expiration monitoring and regulatory compliance.

An external identifier or pointer in pharmacy and drug database systems linking a drug preparation type to a source reference such as USP monographs, compounding guidelines, or formulary documents. Used in PBM, EHR, and compounding platforms to maintain traceability and support regulatory compliance auditing.

The date on which a drug formulation issue, hold, recall, or clinical review was formally resolved or closed in the pharmacy or drug management system. Used to track the lifecycle of formulation-related problems including safety alerts, compounding errors, and formulary reviews.

The breathing rate value for a drug preparation type. Used in healthcare data management and clinical workflows. This field is commonly used in electronic health records (EHR), healthcare information systems (HIS), and clinical data warehouses for formulation management and reporting.

Documents the body systems or clinical review criteria evaluated in relation to a drug formulation's therapeutic application, used in pharmacy informatics and clinical decision support systems to associate formulations with relevant organ systems for prescribing appropriateness and drug-disease interaction checks.

Tracks the version or iteration number of a drug formulation record, indicating how many times the formulation's composition, strength, instructions, or regulatory information has been updated. Used in pharmacy data systems to maintain audit trails and ensure the most current formulation specifications are applied.

Represents the assessed risk level associated with a specific drug formulation, including factors such as narrow therapeutic index, high-alert medication status, or compounding hazards. Used in pharmacy safety programs, clinical risk stratification, and medication management protocols to flag formulations requiring heightened oversight.

Specifies the administration pathway for a drug formulation, such as oral, intravenous, topical, or inhaled. Used in pharmacy dispensing systems, medication order management, and clinical databases to ensure the correct delivery method is matched to the formulation type for safe and effective drug administration.

A calculated numeric rating assigned to a drug preparation type in pharmacy analytics or formulary management systems, reflecting quality, efficacy, or preference ranking. Used in PBM formulary decision engines and clinical decision support tools within EHR platforms to prioritize drug selection and support therapeutic substitution logic.

An integer ordering field in pharmacy and drug master file systems that defines the processing or display order of drug preparation types within a formulary, compounding workflow, or medication record. Used in PBM adjudication engines and EHR medication management modules to ensure consistent drug selection logic and data rendering.

A date field in pharmacy, PBM, and EHR systems capturing when a specific drug preparation type was dispensed or administered to a patient. Used in claims adjudication, medication reconciliation, and utilization management workflows to establish timelines for drug therapy episodes, prior authorization windows, and clinical outcomes tracking.

A coded or descriptive attribute in pharmacy and clinical data systems indicating the seriousness level associated with a drug preparation type, often linked to adverse event risk or clinical condition acuity. Used in EHR clinical decision support, PBM drug utilization review, and pharmacovigilance workflows to trigger safety alerts and management protocols.

Identifies the biological sex classification associated with a drug formulation record, used in pharmaceutical databases to denote sex-specific formulations, dosing guidelines, or clinical indications where biological sex influences drug metabolism, efficacy, or safety parameters in prescribing and dispensing workflows.

Identifies the reference system or database from which a drug preparation type originates, such as FDA NDC directory, FDB, or Medi-Span. Used in pharmacy, PBM, and EHR systems to trace drug formulation lineage and support formulary management workflows.

Records the effective begin date for a specific drug preparation type within pharmacy or PBM systems, marking when a formulation became clinically or commercially available. Critical for formulary versioning, drug history tracking, and claims adjudication in EHR and PBM platforms.

Records the specific time at which a drug formulation preparation, infusion, or administration process was initiated. Used in pharmacy compounding logs, inpatient medication administration records, and IV preparation tracking systems to ensure timing accuracy and compliance with stability and dosing interval requirements.

Indicates the physical state or jurisdiction-related state attribute of a drug formulation. In physical terms, this may represent solid, liquid, or gas form. In regulatory contexts, it captures the U.S. state governing compounding or dispensing authority, used in pharmacy licensure and drug distribution compliance records.

Indicates the current lifecycle state of a drug preparation type, such as active, inactive, discontinued, or pending approval. Used in pharmacy systems, PBM formulary management, and EHR drug databases to govern prescribing eligibility and claims processing rules.

Records the street-level address associated with the facility where a drug formulation is compounded, manufactured, or distributed. Used in pharmacy regulatory records, compounding facility registrations, and pharmaceutical supply chain documentation to establish the physical location of drug preparation for compliance and traceability.